Semax-Aetic, N-acetyl-semax peptide, acetylated semax · Evidence-based safety and harm-reduction overview.
| Also known as | Semax-Aetic, N-acetyl-semax peptide, acetylated semax |
| Category | Peptide |
| heptapeptide | True |
| acth_derivative | True |
| russian_pharmaceutical | True |
| US legal status | Not FDA-approved for human use in the United States. Available in Russia and some Eastern European countries as a pharmaceutical agent. Not a dietary supplement. Regulatory status varies by jurisdiction; not approved for general use in Western countries. |
A synthetic heptapeptide (7 amino acids: Met-Glu-His-Phe-Pro-Gly-Pro) with an N-terminal acetyl group. Derivative of ACTH 4-7; functions as a neuropeptide enhancing cognitive function, neuroprotection, and stress resilience. Proposed mechanism involves neurotransmitter and growth factor modulation.
N-Acetyl-Semax enhances BDNF and GDNF production via ACTH-related pathways. It also modulates monoamine and neuropeptide Y signaling, supporting stress resilience.
Developed in Russia in 1987 as a modified ACTH fragment. Used clinically in Russia and Eastern Europe for cognitive and neurological indications; minimal Western adoption.
Russian and Eastern European clinical trials report improvements in cognitive function, recovery from stroke, and stress resilience. Some small human studies show modest effects on cognition and mood. Western peer-reviewed research is limited and mixed. Evidence quality is lower than modern standards. Efficacy in healthy individuals is debated; most benefits suggested in clinical populations.
Russian protocols used 1-2 mg daily via injection or nasal spray. Western dosing protocols absent; optimal regimens unknown.
This is general research/context information, not medical advice or a recommended protocol.
N-Acetyl-Semax combined with other cognitive or neuroprotective peptides is theoretical; Western safety data absent.
If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsNo. N-Acetyl-Semax is not FDA-approved and is not available as a legal pharmaceutical product in the United States. It is available in Russia and some Eastern European countries.
N-Acetyl-Semax has an acetyl group added to improve stability and bioavailability. It is a modified version of the parent compound Semax.
Russian clinical trials report modest cognitive benefits, but Western peer-reviewed research is limited. Effects are generally modest and most notable in clinical populations with neurological deficits.
N-Acetyl-Semax is typically administered as an injection or nasal spray. Oral administration would not be effective due to peptide digestion by stomach acid.
Safety data are limited to Russian studies with modest adverse event reporting. Western safety characterization is absent; long-term effects unknown.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.